Medical Care
Global Neurological Disease Model Market Research Report 2025
- Jul 14, 25
- ID: 374379
- Pages: 92
- Figures: 99
- Views: 12
The global market for Neurological Disease Model was valued at US$ 877 million in the year 2024 and is projected to reach a revised size of US$ 1483 million by 2031, growing at a CAGR of 7.8% during the forecast period.
The Neurological Disease Model refers to a standardized research system that simulates specific pathological features of human nervous system disorders in experimental animals or cellular systems through genetic editing, chemical induction, physical injury, or behavioral interventions. It provides a reproducible experimental platform for elucidating disease mechanisms, screening therapeutic targets, and evaluating drug efficacy, with broad applications in mechanistic research and preclinical translation of neurodegenerative, psychiatric, and neurodevelopmental disorders.
North American market for Neurological Disease Model is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Neurological Disease Model is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Neurological Disease Model in Clinical Diagnosis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Neurological Disease Model include Axion BioSystems, Creative Biolabs, Taconic Biosciences, Charles River Laboratories, The Jackson Laboratories, Ozgene, Shanghai Model Organisms Center, Inc., Brin Case Biotechnology Co., Ltd., OBiO Technology ( Shanghai ) Corp.,Ltd., BrainVTA (Wuhan) Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neurological Disease Model, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurological Disease Model.
The Neurological Disease Model market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurological Disease Model market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurological Disease Model companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Axion BioSystems
Creative Biolabs
Taconic Biosciences
Charles River Laboratories
The Jackson Laboratories
Ozgene
Shanghai Model Organisms Center, Inc.
Brin Case Biotechnology Co., Ltd.
OBiO Technology ( Shanghai ) Corp.,Ltd.
BrainVTA (Wuhan) Co., Ltd.
GemPharmatech Co., Ltd.
Jiangsu Ailingfei Biotechnology Co., Ltd.
Beijing Biocytogen Co., Ltd.
Kunming Biomed International Ltd.
Beijing Viewsolid Biotechnology Co., Ltd.
Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd.
Sichuan Greentech Biotechnology Co., Ltd.
Pharmalegacy Laboratories (Shanghai) Co., Ltd.
Segment by Type
Parkinson's Disease Model
Alzheimer's Disease Model
Anxiety Model
Depression Model
Traumatic Brain/Spinal Cord Injury Model
Neonatal Hypoxic-Ischemic Encephalopathy Model
注：
Others
Segment by Application
Clinical Diagnosis
Scientific Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurological Disease Model company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Neurological Disease Model refers to a standardized research system that simulates specific pathological features of human nervous system disorders in experimental animals or cellular systems through genetic editing, chemical induction, physical injury, or behavioral interventions. It provides a reproducible experimental platform for elucidating disease mechanisms, screening therapeutic targets, and evaluating drug efficacy, with broad applications in mechanistic research and preclinical translation of neurodegenerative, psychiatric, and neurodevelopmental disorders.
North American market for Neurological Disease Model is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Neurological Disease Model is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Neurological Disease Model in Clinical Diagnosis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Neurological Disease Model include Axion BioSystems, Creative Biolabs, Taconic Biosciences, Charles River Laboratories, The Jackson Laboratories, Ozgene, Shanghai Model Organisms Center, Inc., Brin Case Biotechnology Co., Ltd., OBiO Technology ( Shanghai ) Corp.,Ltd., BrainVTA (Wuhan) Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neurological Disease Model, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurological Disease Model.
The Neurological Disease Model market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurological Disease Model market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurological Disease Model companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Axion BioSystems
Creative Biolabs
Taconic Biosciences
Charles River Laboratories
The Jackson Laboratories
Ozgene
Shanghai Model Organisms Center, Inc.
Brin Case Biotechnology Co., Ltd.
OBiO Technology ( Shanghai ) Corp.,Ltd.
BrainVTA (Wuhan) Co., Ltd.
GemPharmatech Co., Ltd.
Jiangsu Ailingfei Biotechnology Co., Ltd.
Beijing Biocytogen Co., Ltd.
Kunming Biomed International Ltd.
Beijing Viewsolid Biotechnology Co., Ltd.
Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd.
Sichuan Greentech Biotechnology Co., Ltd.
Pharmalegacy Laboratories (Shanghai) Co., Ltd.
Segment by Type
Parkinson's Disease Model
Alzheimer's Disease Model
Anxiety Model
Depression Model
Traumatic Brain/Spinal Cord Injury Model
Neonatal Hypoxic-Ischemic Encephalopathy Model
注：
Others
Segment by Application
Clinical Diagnosis
Scientific Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurological Disease Model company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurological Disease Model Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Parkinson's Disease Model
1.2.3 Alzheimer's Disease Model
1.2.4 Anxiety Model
1.2.5 Depression Model
1.2.6 Traumatic Brain/Spinal Cord Injury Model
1.2.7 Neonatal Hypoxic-Ischemic Encephalopathy Model
注：
1.2.8 Others
1.3 Market by Application
1.3.1 Global Neurological Disease Model Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurological Disease Model Market Perspective (2020-2031)
2.2 Global Neurological Disease Model Growth Trends by Region
2.2.1 Global Neurological Disease Model Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neurological Disease Model Historic Market Size by Region (2020-2025)
2.2.3 Neurological Disease Model Forecasted Market Size by Region (2026-2031)
2.3 Neurological Disease Model Market Dynamics
2.3.1 Neurological Disease Model Industry Trends
2.3.2 Neurological Disease Model Market Drivers
2.3.3 Neurological Disease Model Market Challenges
2.3.4 Neurological Disease Model Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurological Disease Model Players by Revenue
3.1.1 Global Top Neurological Disease Model Players by Revenue (2020-2025)
3.1.2 Global Neurological Disease Model Revenue Market Share by Players (2020-2025)
3.2 Global Top Neurological Disease Model Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neurological Disease Model Revenue
3.4 Global Neurological Disease Model Market Concentration Ratio
3.4.1 Global Neurological Disease Model Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurological Disease Model Revenue in 2024
3.5 Global Key Players of Neurological Disease Model Head office and Area Served
3.6 Global Key Players of Neurological Disease Model, Product and Application
3.7 Global Key Players of Neurological Disease Model, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurological Disease Model Breakdown Data by Type
4.1 Global Neurological Disease Model Historic Market Size by Type (2020-2025)
4.2 Global Neurological Disease Model Forecasted Market Size by Type (2026-2031)
5 Neurological Disease Model Breakdown Data by Application
5.1 Global Neurological Disease Model Historic Market Size by Application (2020-2025)
5.2 Global Neurological Disease Model Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neurological Disease Model Market Size (2020-2031)
6.2 North America Neurological Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neurological Disease Model Market Size by Country (2020-2025)
6.4 North America Neurological Disease Model Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurological Disease Model Market Size (2020-2031)
7.2 Europe Neurological Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neurological Disease Model Market Size by Country (2020-2025)
7.4 Europe Neurological Disease Model Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Neurological Disease Model Market Size (2020-2031)
8.2 Asia-Pacific Neurological Disease Model Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neurological Disease Model Market Size by Region (2020-2025)
8.4 Asia-Pacific Neurological Disease Model Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Neurological Disease Model Market Size (2020-2031)
9.2 Latin America Neurological Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neurological Disease Model Market Size by Country (2020-2025)
9.4 Latin America Neurological Disease Model Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurological Disease Model Market Size (2020-2031)
10.2 Middle East & Africa Neurological Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neurological Disease Model Market Size by Country (2020-2025)
10.4 Middle East & Africa Neurological Disease Model Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Axion BioSystems
11.1.1 Axion BioSystems Company Details
11.1.2 Axion BioSystems Business Overview
11.1.3 Axion BioSystems Neurological Disease Model Introduction
11.1.4 Axion BioSystems Revenue in Neurological Disease Model Business (2020-2025)
11.1.5 Axion BioSystems Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Neurological Disease Model Introduction
11.2.4 Creative Biolabs Revenue in Neurological Disease Model Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Taconic Biosciences
11.3.1 Taconic Biosciences Company Details
11.3.2 Taconic Biosciences Business Overview
11.3.3 Taconic Biosciences Neurological Disease Model Introduction
11.3.4 Taconic Biosciences Revenue in Neurological Disease Model Business (2020-2025)
11.3.5 Taconic Biosciences Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Neurological Disease Model Introduction
11.4.4 Charles River Laboratories Revenue in Neurological Disease Model Business (2020-2025)
11.4.5 Charles River Laboratories Recent Development
11.5 The Jackson Laboratories
11.5.1 The Jackson Laboratories Company Details
11.5.2 The Jackson Laboratories Business Overview
11.5.3 The Jackson Laboratories Neurological Disease Model Introduction
11.5.4 The Jackson Laboratories Revenue in Neurological Disease Model Business (2020-2025)
11.5.5 The Jackson Laboratories Recent Development
11.6 Ozgene
11.6.1 Ozgene Company Details
11.6.2 Ozgene Business Overview
11.6.3 Ozgene Neurological Disease Model Introduction
11.6.4 Ozgene Revenue in Neurological Disease Model Business (2020-2025)
11.6.5 Ozgene Recent Development
11.7 Shanghai Model Organisms Center, Inc.
11.7.1 Shanghai Model Organisms Center, Inc. Company Details
11.7.2 Shanghai Model Organisms Center, Inc. Business Overview
11.7.3 Shanghai Model Organisms Center, Inc. Neurological Disease Model Introduction
11.7.4 Shanghai Model Organisms Center, Inc. Revenue in Neurological Disease Model Business (2020-2025)
11.7.5 Shanghai Model Organisms Center, Inc. Recent Development
11.8 Brin Case Biotechnology Co., Ltd.
11.8.1 Brin Case Biotechnology Co., Ltd. Company Details
11.8.2 Brin Case Biotechnology Co., Ltd. Business Overview
11.8.3 Brin Case Biotechnology Co., Ltd. Neurological Disease Model Introduction
11.8.4 Brin Case Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.8.5 Brin Case Biotechnology Co., Ltd. Recent Development
11.9 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.9.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
11.9.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
11.9.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Neurological Disease Model Introduction
11.9.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.9.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
11.10 BrainVTA (Wuhan) Co., Ltd.
11.10.1 BrainVTA (Wuhan) Co., Ltd. Company Details
11.10.2 BrainVTA (Wuhan) Co., Ltd. Business Overview
11.10.3 BrainVTA (Wuhan) Co., Ltd. Neurological Disease Model Introduction
11.10.4 BrainVTA (Wuhan) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.10.5 BrainVTA (Wuhan) Co., Ltd. Recent Development
11.11 GemPharmatech Co., Ltd.
11.11.1 GemPharmatech Co., Ltd. Company Details
11.11.2 GemPharmatech Co., Ltd. Business Overview
11.11.3 GemPharmatech Co., Ltd. Neurological Disease Model Introduction
11.11.4 GemPharmatech Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.11.5 GemPharmatech Co., Ltd. Recent Development
11.12 Jiangsu Ailingfei Biotechnology Co., Ltd.
11.12.1 Jiangsu Ailingfei Biotechnology Co., Ltd. Company Details
11.12.2 Jiangsu Ailingfei Biotechnology Co., Ltd. Business Overview
11.12.3 Jiangsu Ailingfei Biotechnology Co., Ltd. Neurological Disease Model Introduction
11.12.4 Jiangsu Ailingfei Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.12.5 Jiangsu Ailingfei Biotechnology Co., Ltd. Recent Development
11.13 Beijing Biocytogen Co., Ltd.
11.13.1 Beijing Biocytogen Co., Ltd. Company Details
11.13.2 Beijing Biocytogen Co., Ltd. Business Overview
11.13.3 Beijing Biocytogen Co., Ltd. Neurological Disease Model Introduction
11.13.4 Beijing Biocytogen Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.13.5 Beijing Biocytogen Co., Ltd. Recent Development
11.14 Kunming Biomed International Ltd.
11.14.1 Kunming Biomed International Ltd. Company Details
11.14.2 Kunming Biomed International Ltd. Business Overview
11.14.3 Kunming Biomed International Ltd. Neurological Disease Model Introduction
11.14.4 Kunming Biomed International Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.14.5 Kunming Biomed International Ltd. Recent Development
11.15 Beijing Viewsolid Biotechnology Co., Ltd.
11.15.1 Beijing Viewsolid Biotechnology Co., Ltd. Company Details
11.15.2 Beijing Viewsolid Biotechnology Co., Ltd. Business Overview
11.15.3 Beijing Viewsolid Biotechnology Co., Ltd. Neurological Disease Model Introduction
11.15.4 Beijing Viewsolid Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.15.5 Beijing Viewsolid Biotechnology Co., Ltd. Recent Development
11.16 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd.
11.16.1 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Company Details
11.16.2 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Business Overview
11.16.3 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Neurological Disease Model Introduction
11.16.4 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.16.5 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Recent Development
11.17 Sichuan Greentech Biotechnology Co., Ltd.
11.17.1 Sichuan Greentech Biotechnology Co., Ltd. Company Details
11.17.2 Sichuan Greentech Biotechnology Co., Ltd. Business Overview
11.17.3 Sichuan Greentech Biotechnology Co., Ltd. Neurological Disease Model Introduction
11.17.4 Sichuan Greentech Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.17.5 Sichuan Greentech Biotechnology Co., Ltd. Recent Development
11.18 Pharmalegacy Laboratories (Shanghai) Co., Ltd.
11.18.1 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Company Details
11.18.2 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Business Overview
11.18.3 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Neurological Disease Model Introduction
11.18.4 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.18.5 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurological Disease Model Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Parkinson's Disease Model
1.2.3 Alzheimer's Disease Model
1.2.4 Anxiety Model
1.2.5 Depression Model
1.2.6 Traumatic Brain/Spinal Cord Injury Model
1.2.7 Neonatal Hypoxic-Ischemic Encephalopathy Model
注：
1.2.8 Others
1.3 Market by Application
1.3.1 Global Neurological Disease Model Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurological Disease Model Market Perspective (2020-2031)
2.2 Global Neurological Disease Model Growth Trends by Region
2.2.1 Global Neurological Disease Model Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neurological Disease Model Historic Market Size by Region (2020-2025)
2.2.3 Neurological Disease Model Forecasted Market Size by Region (2026-2031)
2.3 Neurological Disease Model Market Dynamics
2.3.1 Neurological Disease Model Industry Trends
2.3.2 Neurological Disease Model Market Drivers
2.3.3 Neurological Disease Model Market Challenges
2.3.4 Neurological Disease Model Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurological Disease Model Players by Revenue
3.1.1 Global Top Neurological Disease Model Players by Revenue (2020-2025)
3.1.2 Global Neurological Disease Model Revenue Market Share by Players (2020-2025)
3.2 Global Top Neurological Disease Model Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neurological Disease Model Revenue
3.4 Global Neurological Disease Model Market Concentration Ratio
3.4.1 Global Neurological Disease Model Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurological Disease Model Revenue in 2024
3.5 Global Key Players of Neurological Disease Model Head office and Area Served
3.6 Global Key Players of Neurological Disease Model, Product and Application
3.7 Global Key Players of Neurological Disease Model, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurological Disease Model Breakdown Data by Type
4.1 Global Neurological Disease Model Historic Market Size by Type (2020-2025)
4.2 Global Neurological Disease Model Forecasted Market Size by Type (2026-2031)
5 Neurological Disease Model Breakdown Data by Application
5.1 Global Neurological Disease Model Historic Market Size by Application (2020-2025)
5.2 Global Neurological Disease Model Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neurological Disease Model Market Size (2020-2031)
6.2 North America Neurological Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neurological Disease Model Market Size by Country (2020-2025)
6.4 North America Neurological Disease Model Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurological Disease Model Market Size (2020-2031)
7.2 Europe Neurological Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neurological Disease Model Market Size by Country (2020-2025)
7.4 Europe Neurological Disease Model Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Neurological Disease Model Market Size (2020-2031)
8.2 Asia-Pacific Neurological Disease Model Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neurological Disease Model Market Size by Region (2020-2025)
8.4 Asia-Pacific Neurological Disease Model Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Neurological Disease Model Market Size (2020-2031)
9.2 Latin America Neurological Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neurological Disease Model Market Size by Country (2020-2025)
9.4 Latin America Neurological Disease Model Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurological Disease Model Market Size (2020-2031)
10.2 Middle East & Africa Neurological Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neurological Disease Model Market Size by Country (2020-2025)
10.4 Middle East & Africa Neurological Disease Model Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Axion BioSystems
11.1.1 Axion BioSystems Company Details
11.1.2 Axion BioSystems Business Overview
11.1.3 Axion BioSystems Neurological Disease Model Introduction
11.1.4 Axion BioSystems Revenue in Neurological Disease Model Business (2020-2025)
11.1.5 Axion BioSystems Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Neurological Disease Model Introduction
11.2.4 Creative Biolabs Revenue in Neurological Disease Model Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Taconic Biosciences
11.3.1 Taconic Biosciences Company Details
11.3.2 Taconic Biosciences Business Overview
11.3.3 Taconic Biosciences Neurological Disease Model Introduction
11.3.4 Taconic Biosciences Revenue in Neurological Disease Model Business (2020-2025)
11.3.5 Taconic Biosciences Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Neurological Disease Model Introduction
11.4.4 Charles River Laboratories Revenue in Neurological Disease Model Business (2020-2025)
11.4.5 Charles River Laboratories Recent Development
11.5 The Jackson Laboratories
11.5.1 The Jackson Laboratories Company Details
11.5.2 The Jackson Laboratories Business Overview
11.5.3 The Jackson Laboratories Neurological Disease Model Introduction
11.5.4 The Jackson Laboratories Revenue in Neurological Disease Model Business (2020-2025)
11.5.5 The Jackson Laboratories Recent Development
11.6 Ozgene
11.6.1 Ozgene Company Details
11.6.2 Ozgene Business Overview
11.6.3 Ozgene Neurological Disease Model Introduction
11.6.4 Ozgene Revenue in Neurological Disease Model Business (2020-2025)
11.6.5 Ozgene Recent Development
11.7 Shanghai Model Organisms Center, Inc.
11.7.1 Shanghai Model Organisms Center, Inc. Company Details
11.7.2 Shanghai Model Organisms Center, Inc. Business Overview
11.7.3 Shanghai Model Organisms Center, Inc. Neurological Disease Model Introduction
11.7.4 Shanghai Model Organisms Center, Inc. Revenue in Neurological Disease Model Business (2020-2025)
11.7.5 Shanghai Model Organisms Center, Inc. Recent Development
11.8 Brin Case Biotechnology Co., Ltd.
11.8.1 Brin Case Biotechnology Co., Ltd. Company Details
11.8.2 Brin Case Biotechnology Co., Ltd. Business Overview
11.8.3 Brin Case Biotechnology Co., Ltd. Neurological Disease Model Introduction
11.8.4 Brin Case Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.8.5 Brin Case Biotechnology Co., Ltd. Recent Development
11.9 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.9.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
11.9.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
11.9.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Neurological Disease Model Introduction
11.9.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.9.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
11.10 BrainVTA (Wuhan) Co., Ltd.
11.10.1 BrainVTA (Wuhan) Co., Ltd. Company Details
11.10.2 BrainVTA (Wuhan) Co., Ltd. Business Overview
11.10.3 BrainVTA (Wuhan) Co., Ltd. Neurological Disease Model Introduction
11.10.4 BrainVTA (Wuhan) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.10.5 BrainVTA (Wuhan) Co., Ltd. Recent Development
11.11 GemPharmatech Co., Ltd.
11.11.1 GemPharmatech Co., Ltd. Company Details
11.11.2 GemPharmatech Co., Ltd. Business Overview
11.11.3 GemPharmatech Co., Ltd. Neurological Disease Model Introduction
11.11.4 GemPharmatech Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.11.5 GemPharmatech Co., Ltd. Recent Development
11.12 Jiangsu Ailingfei Biotechnology Co., Ltd.
11.12.1 Jiangsu Ailingfei Biotechnology Co., Ltd. Company Details
11.12.2 Jiangsu Ailingfei Biotechnology Co., Ltd. Business Overview
11.12.3 Jiangsu Ailingfei Biotechnology Co., Ltd. Neurological Disease Model Introduction
11.12.4 Jiangsu Ailingfei Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.12.5 Jiangsu Ailingfei Biotechnology Co., Ltd. Recent Development
11.13 Beijing Biocytogen Co., Ltd.
11.13.1 Beijing Biocytogen Co., Ltd. Company Details
11.13.2 Beijing Biocytogen Co., Ltd. Business Overview
11.13.3 Beijing Biocytogen Co., Ltd. Neurological Disease Model Introduction
11.13.4 Beijing Biocytogen Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.13.5 Beijing Biocytogen Co., Ltd. Recent Development
11.14 Kunming Biomed International Ltd.
11.14.1 Kunming Biomed International Ltd. Company Details
11.14.2 Kunming Biomed International Ltd. Business Overview
11.14.3 Kunming Biomed International Ltd. Neurological Disease Model Introduction
11.14.4 Kunming Biomed International Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.14.5 Kunming Biomed International Ltd. Recent Development
11.15 Beijing Viewsolid Biotechnology Co., Ltd.
11.15.1 Beijing Viewsolid Biotechnology Co., Ltd. Company Details
11.15.2 Beijing Viewsolid Biotechnology Co., Ltd. Business Overview
11.15.3 Beijing Viewsolid Biotechnology Co., Ltd. Neurological Disease Model Introduction
11.15.4 Beijing Viewsolid Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.15.5 Beijing Viewsolid Biotechnology Co., Ltd. Recent Development
11.16 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd.
11.16.1 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Company Details
11.16.2 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Business Overview
11.16.3 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Neurological Disease Model Introduction
11.16.4 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.16.5 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Recent Development
11.17 Sichuan Greentech Biotechnology Co., Ltd.
11.17.1 Sichuan Greentech Biotechnology Co., Ltd. Company Details
11.17.2 Sichuan Greentech Biotechnology Co., Ltd. Business Overview
11.17.3 Sichuan Greentech Biotechnology Co., Ltd. Neurological Disease Model Introduction
11.17.4 Sichuan Greentech Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.17.5 Sichuan Greentech Biotechnology Co., Ltd. Recent Development
11.18 Pharmalegacy Laboratories (Shanghai) Co., Ltd.
11.18.1 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Company Details
11.18.2 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Business Overview
11.18.3 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Neurological Disease Model Introduction
11.18.4 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025)
11.18.5 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neurological Disease Model Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Parkinson's Disease Model
Table 3. Key Players of Alzheimer's Disease Model
Table 4. Key Players of Anxiety Model
Table 5. Key Players of Depression Model
Table 6. Key Players of Traumatic Brain/Spinal Cord Injury Model
Table 7. Key Players of Neonatal Hypoxic-Ischemic Encephalopathy Model
注：
Table 8. Key Players of Others
Table 9. Global Neurological Disease Model Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Neurological Disease Model Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Neurological Disease Model Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Neurological Disease Model Market Share by Region (2020-2025)
Table 13. Global Neurological Disease Model Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Neurological Disease Model Market Share by Region (2026-2031)
Table 15. Neurological Disease Model Market Trends
Table 16. Neurological Disease Model Market Drivers
Table 17. Neurological Disease Model Market Challenges
Table 18. Neurological Disease Model Market Restraints
Table 19. Global Neurological Disease Model Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Neurological Disease Model Market Share by Players (2020-2025)
Table 21. Global Top Neurological Disease Model Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disease Model as of 2024)
Table 22. Ranking of Global Top Neurological Disease Model Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Neurological Disease Model Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Neurological Disease Model, Headquarters and Area Served
Table 25. Global Key Players of Neurological Disease Model, Product and Application
Table 26. Global Key Players of Neurological Disease Model, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neurological Disease Model Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Neurological Disease Model Revenue Market Share by Type (2020-2025)
Table 30. Global Neurological Disease Model Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Neurological Disease Model Revenue Market Share by Type (2026-2031)
Table 32. Global Neurological Disease Model Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Neurological Disease Model Revenue Market Share by Application (2020-2025)
Table 34. Global Neurological Disease Model Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Neurological Disease Model Revenue Market Share by Application (2026-2031)
Table 36. North America Neurological Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Neurological Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Neurological Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Neurological Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Neurological Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Neurological Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Neurological Disease Model Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Neurological Disease Model Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Neurological Disease Model Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Neurological Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Neurological Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Neurological Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Neurological Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Neurological Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Neurological Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 51. Axion BioSystems Company Details
Table 52. Axion BioSystems Business Overview
Table 53. Axion BioSystems Neurological Disease Model Product
Table 54. Axion BioSystems Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 55. Axion BioSystems Recent Development
Table 56. Creative Biolabs Company Details
Table 57. Creative Biolabs Business Overview
Table 58. Creative Biolabs Neurological Disease Model Product
Table 59. Creative Biolabs Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 60. Creative Biolabs Recent Development
Table 61. Taconic Biosciences Company Details
Table 62. Taconic Biosciences Business Overview
Table 63. Taconic Biosciences Neurological Disease Model Product
Table 64. Taconic Biosciences Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 65. Taconic Biosciences Recent Development
Table 66. Charles River Laboratories Company Details
Table 67. Charles River Laboratories Business Overview
Table 68. Charles River Laboratories Neurological Disease Model Product
Table 69. Charles River Laboratories Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 70. Charles River Laboratories Recent Development
Table 71. The Jackson Laboratories Company Details
Table 72. The Jackson Laboratories Business Overview
Table 73. The Jackson Laboratories Neurological Disease Model Product
Table 74. The Jackson Laboratories Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 75. The Jackson Laboratories Recent Development
Table 76. Ozgene Company Details
Table 77. Ozgene Business Overview
Table 78. Ozgene Neurological Disease Model Product
Table 79. Ozgene Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 80. Ozgene Recent Development
Table 81. Shanghai Model Organisms Center, Inc. Company Details
Table 82. Shanghai Model Organisms Center, Inc. Business Overview
Table 83. Shanghai Model Organisms Center, Inc. Neurological Disease Model Product
Table 84. Shanghai Model Organisms Center, Inc. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 85. Shanghai Model Organisms Center, Inc. Recent Development
Table 86. Brin Case Biotechnology Co., Ltd. Company Details
Table 87. Brin Case Biotechnology Co., Ltd. Business Overview
Table 88. Brin Case Biotechnology Co., Ltd. Neurological Disease Model Product
Table 89. Brin Case Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 90. Brin Case Biotechnology Co., Ltd. Recent Development
Table 91. OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
Table 92. OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
Table 93. OBiO Technology ( Shanghai ) Corp.,Ltd. Neurological Disease Model Product
Table 94. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 95. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
Table 96. BrainVTA (Wuhan) Co., Ltd. Company Details
Table 97. BrainVTA (Wuhan) Co., Ltd. Business Overview
Table 98. BrainVTA (Wuhan) Co., Ltd. Neurological Disease Model Product
Table 99. BrainVTA (Wuhan) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 100. BrainVTA (Wuhan) Co., Ltd. Recent Development
Table 101. GemPharmatech Co., Ltd. Company Details
Table 102. GemPharmatech Co., Ltd. Business Overview
Table 103. GemPharmatech Co., Ltd. Neurological Disease Model Product
Table 104. GemPharmatech Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 105. GemPharmatech Co., Ltd. Recent Development
Table 106. Jiangsu Ailingfei Biotechnology Co., Ltd. Company Details
Table 107. Jiangsu Ailingfei Biotechnology Co., Ltd. Business Overview
Table 108. Jiangsu Ailingfei Biotechnology Co., Ltd. Neurological Disease Model Product
Table 109. Jiangsu Ailingfei Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 110. Jiangsu Ailingfei Biotechnology Co., Ltd. Recent Development
Table 111. Beijing Biocytogen Co., Ltd. Company Details
Table 112. Beijing Biocytogen Co., Ltd. Business Overview
Table 113. Beijing Biocytogen Co., Ltd. Neurological Disease Model Product
Table 114. Beijing Biocytogen Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 115. Beijing Biocytogen Co., Ltd. Recent Development
Table 116. Kunming Biomed International Ltd. Company Details
Table 117. Kunming Biomed International Ltd. Business Overview
Table 118. Kunming Biomed International Ltd. Neurological Disease Model Product
Table 119. Kunming Biomed International Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 120. Kunming Biomed International Ltd. Recent Development
Table 121. Beijing Viewsolid Biotechnology Co., Ltd. Company Details
Table 122. Beijing Viewsolid Biotechnology Co., Ltd. Business Overview
Table 123. Beijing Viewsolid Biotechnology Co., Ltd. Neurological Disease Model Product
Table 124. Beijing Viewsolid Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 125. Beijing Viewsolid Biotechnology Co., Ltd. Recent Development
Table 126. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Company Details
Table 127. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Business Overview
Table 128. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Neurological Disease Model Product
Table 129. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 130. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Recent Development
Table 131. Sichuan Greentech Biotechnology Co., Ltd. Company Details
Table 132. Sichuan Greentech Biotechnology Co., Ltd. Business Overview
Table 133. Sichuan Greentech Biotechnology Co., Ltd. Neurological Disease Model Product
Table 134. Sichuan Greentech Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 135. Sichuan Greentech Biotechnology Co., Ltd. Recent Development
Table 136. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Company Details
Table 137. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Business Overview
Table 138. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Neurological Disease Model Product
Table 139. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 140. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report
List of Figures
Figure 1. Neurological Disease Model Picture
Figure 2. Global Neurological Disease Model Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neurological Disease Model Market Share by Type: 2024 VS 2031
Figure 4. Parkinson's Disease Model Features
Figure 5. Alzheimer's Disease Model Features
Figure 6. Anxiety Model Features
Figure 7. Depression Model Features
Figure 8. Traumatic Brain/Spinal Cord Injury Model Features
Figure 9. Neonatal Hypoxic-Ischemic Encephalopathy Model
注： Features
Figure 10. Others Features
Figure 11. Global Neurological Disease Model Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Neurological Disease Model Market Share by Application: 2024 VS 2031
Figure 13. Clinical Diagnosis Case Studies
Figure 14. Scientific Research Case Studies
Figure 15. Others Case Studies
Figure 16. Neurological Disease Model Report Years Considered
Figure 17. Global Neurological Disease Model Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Neurological Disease Model Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Neurological Disease Model Market Share by Region: 2024 VS 2031
Figure 20. Global Neurological Disease Model Market Share by Players in 2024
Figure 21. Global Neurological Disease Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Neurological Disease Model Revenue in 2024
Figure 23. North America Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Neurological Disease Model Market Share by Country (2020-2031)
Figure 25. United States Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Neurological Disease Model Market Share by Country (2020-2031)
Figure 29. Germany Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Ireland Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Neurological Disease Model Market Share by Region (2020-2031)
Figure 37. China Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia & New Zealand Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Neurological Disease Model Market Share by Country (2020-2031)
Figure 45. Mexico Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Neurological Disease Model Market Share by Country (2020-2031)
Figure 49. Israel Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Axion BioSystems Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 53. Creative Biolabs Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 54. Taconic Biosciences Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 55. Charles River Laboratories Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 56. The Jackson Laboratories Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 57. Ozgene Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 58. Shanghai Model Organisms Center, Inc. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 59. Brin Case Biotechnology Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 60. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 61. BrainVTA (Wuhan) Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 62. GemPharmatech Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 63. Jiangsu Ailingfei Biotechnology Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 64. Beijing Biocytogen Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 65. Kunming Biomed International Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 66. Beijing Viewsolid Biotechnology Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 67. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 68. Sichuan Greentech Biotechnology Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 69. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Neurological Disease Model Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Parkinson's Disease Model
Table 3. Key Players of Alzheimer's Disease Model
Table 4. Key Players of Anxiety Model
Table 5. Key Players of Depression Model
Table 6. Key Players of Traumatic Brain/Spinal Cord Injury Model
Table 7. Key Players of Neonatal Hypoxic-Ischemic Encephalopathy Model
注：
Table 8. Key Players of Others
Table 9. Global Neurological Disease Model Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Neurological Disease Model Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Neurological Disease Model Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Neurological Disease Model Market Share by Region (2020-2025)
Table 13. Global Neurological Disease Model Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Neurological Disease Model Market Share by Region (2026-2031)
Table 15. Neurological Disease Model Market Trends
Table 16. Neurological Disease Model Market Drivers
Table 17. Neurological Disease Model Market Challenges
Table 18. Neurological Disease Model Market Restraints
Table 19. Global Neurological Disease Model Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Neurological Disease Model Market Share by Players (2020-2025)
Table 21. Global Top Neurological Disease Model Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disease Model as of 2024)
Table 22. Ranking of Global Top Neurological Disease Model Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Neurological Disease Model Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Neurological Disease Model, Headquarters and Area Served
Table 25. Global Key Players of Neurological Disease Model, Product and Application
Table 26. Global Key Players of Neurological Disease Model, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neurological Disease Model Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Neurological Disease Model Revenue Market Share by Type (2020-2025)
Table 30. Global Neurological Disease Model Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Neurological Disease Model Revenue Market Share by Type (2026-2031)
Table 32. Global Neurological Disease Model Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Neurological Disease Model Revenue Market Share by Application (2020-2025)
Table 34. Global Neurological Disease Model Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Neurological Disease Model Revenue Market Share by Application (2026-2031)
Table 36. North America Neurological Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Neurological Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Neurological Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Neurological Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Neurological Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Neurological Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Neurological Disease Model Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Neurological Disease Model Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Neurological Disease Model Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Neurological Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Neurological Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Neurological Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Neurological Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Neurological Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Neurological Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 51. Axion BioSystems Company Details
Table 52. Axion BioSystems Business Overview
Table 53. Axion BioSystems Neurological Disease Model Product
Table 54. Axion BioSystems Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 55. Axion BioSystems Recent Development
Table 56. Creative Biolabs Company Details
Table 57. Creative Biolabs Business Overview
Table 58. Creative Biolabs Neurological Disease Model Product
Table 59. Creative Biolabs Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 60. Creative Biolabs Recent Development
Table 61. Taconic Biosciences Company Details
Table 62. Taconic Biosciences Business Overview
Table 63. Taconic Biosciences Neurological Disease Model Product
Table 64. Taconic Biosciences Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 65. Taconic Biosciences Recent Development
Table 66. Charles River Laboratories Company Details
Table 67. Charles River Laboratories Business Overview
Table 68. Charles River Laboratories Neurological Disease Model Product
Table 69. Charles River Laboratories Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 70. Charles River Laboratories Recent Development
Table 71. The Jackson Laboratories Company Details
Table 72. The Jackson Laboratories Business Overview
Table 73. The Jackson Laboratories Neurological Disease Model Product
Table 74. The Jackson Laboratories Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 75. The Jackson Laboratories Recent Development
Table 76. Ozgene Company Details
Table 77. Ozgene Business Overview
Table 78. Ozgene Neurological Disease Model Product
Table 79. Ozgene Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 80. Ozgene Recent Development
Table 81. Shanghai Model Organisms Center, Inc. Company Details
Table 82. Shanghai Model Organisms Center, Inc. Business Overview
Table 83. Shanghai Model Organisms Center, Inc. Neurological Disease Model Product
Table 84. Shanghai Model Organisms Center, Inc. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 85. Shanghai Model Organisms Center, Inc. Recent Development
Table 86. Brin Case Biotechnology Co., Ltd. Company Details
Table 87. Brin Case Biotechnology Co., Ltd. Business Overview
Table 88. Brin Case Biotechnology Co., Ltd. Neurological Disease Model Product
Table 89. Brin Case Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 90. Brin Case Biotechnology Co., Ltd. Recent Development
Table 91. OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
Table 92. OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
Table 93. OBiO Technology ( Shanghai ) Corp.,Ltd. Neurological Disease Model Product
Table 94. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 95. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
Table 96. BrainVTA (Wuhan) Co., Ltd. Company Details
Table 97. BrainVTA (Wuhan) Co., Ltd. Business Overview
Table 98. BrainVTA (Wuhan) Co., Ltd. Neurological Disease Model Product
Table 99. BrainVTA (Wuhan) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 100. BrainVTA (Wuhan) Co., Ltd. Recent Development
Table 101. GemPharmatech Co., Ltd. Company Details
Table 102. GemPharmatech Co., Ltd. Business Overview
Table 103. GemPharmatech Co., Ltd. Neurological Disease Model Product
Table 104. GemPharmatech Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 105. GemPharmatech Co., Ltd. Recent Development
Table 106. Jiangsu Ailingfei Biotechnology Co., Ltd. Company Details
Table 107. Jiangsu Ailingfei Biotechnology Co., Ltd. Business Overview
Table 108. Jiangsu Ailingfei Biotechnology Co., Ltd. Neurological Disease Model Product
Table 109. Jiangsu Ailingfei Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 110. Jiangsu Ailingfei Biotechnology Co., Ltd. Recent Development
Table 111. Beijing Biocytogen Co., Ltd. Company Details
Table 112. Beijing Biocytogen Co., Ltd. Business Overview
Table 113. Beijing Biocytogen Co., Ltd. Neurological Disease Model Product
Table 114. Beijing Biocytogen Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 115. Beijing Biocytogen Co., Ltd. Recent Development
Table 116. Kunming Biomed International Ltd. Company Details
Table 117. Kunming Biomed International Ltd. Business Overview
Table 118. Kunming Biomed International Ltd. Neurological Disease Model Product
Table 119. Kunming Biomed International Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 120. Kunming Biomed International Ltd. Recent Development
Table 121. Beijing Viewsolid Biotechnology Co., Ltd. Company Details
Table 122. Beijing Viewsolid Biotechnology Co., Ltd. Business Overview
Table 123. Beijing Viewsolid Biotechnology Co., Ltd. Neurological Disease Model Product
Table 124. Beijing Viewsolid Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 125. Beijing Viewsolid Biotechnology Co., Ltd. Recent Development
Table 126. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Company Details
Table 127. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Business Overview
Table 128. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Neurological Disease Model Product
Table 129. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 130. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Recent Development
Table 131. Sichuan Greentech Biotechnology Co., Ltd. Company Details
Table 132. Sichuan Greentech Biotechnology Co., Ltd. Business Overview
Table 133. Sichuan Greentech Biotechnology Co., Ltd. Neurological Disease Model Product
Table 134. Sichuan Greentech Biotechnology Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 135. Sichuan Greentech Biotechnology Co., Ltd. Recent Development
Table 136. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Company Details
Table 137. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Business Overview
Table 138. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Neurological Disease Model Product
Table 139. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue in Neurological Disease Model Business (2020-2025) & (US$ Million)
Table 140. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report
List of Figures
Figure 1. Neurological Disease Model Picture
Figure 2. Global Neurological Disease Model Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neurological Disease Model Market Share by Type: 2024 VS 2031
Figure 4. Parkinson's Disease Model Features
Figure 5. Alzheimer's Disease Model Features
Figure 6. Anxiety Model Features
Figure 7. Depression Model Features
Figure 8. Traumatic Brain/Spinal Cord Injury Model Features
Figure 9. Neonatal Hypoxic-Ischemic Encephalopathy Model
注： Features
Figure 10. Others Features
Figure 11. Global Neurological Disease Model Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Neurological Disease Model Market Share by Application: 2024 VS 2031
Figure 13. Clinical Diagnosis Case Studies
Figure 14. Scientific Research Case Studies
Figure 15. Others Case Studies
Figure 16. Neurological Disease Model Report Years Considered
Figure 17. Global Neurological Disease Model Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Neurological Disease Model Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Neurological Disease Model Market Share by Region: 2024 VS 2031
Figure 20. Global Neurological Disease Model Market Share by Players in 2024
Figure 21. Global Neurological Disease Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Neurological Disease Model Revenue in 2024
Figure 23. North America Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Neurological Disease Model Market Share by Country (2020-2031)
Figure 25. United States Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Neurological Disease Model Market Share by Country (2020-2031)
Figure 29. Germany Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Ireland Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Neurological Disease Model Market Share by Region (2020-2031)
Figure 37. China Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia & New Zealand Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Neurological Disease Model Market Share by Country (2020-2031)
Figure 45. Mexico Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Neurological Disease Model Market Share by Country (2020-2031)
Figure 49. Israel Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Neurological Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Axion BioSystems Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 53. Creative Biolabs Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 54. Taconic Biosciences Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 55. Charles River Laboratories Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 56. The Jackson Laboratories Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 57. Ozgene Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 58. Shanghai Model Organisms Center, Inc. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 59. Brin Case Biotechnology Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 60. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 61. BrainVTA (Wuhan) Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 62. GemPharmatech Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 63. Jiangsu Ailingfei Biotechnology Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 64. Beijing Biocytogen Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 65. Kunming Biomed International Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 66. Beijing Viewsolid Biotechnology Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 67. Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 68. Sichuan Greentech Biotechnology Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 69. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue Growth Rate in Neurological Disease Model Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232